Given the parental refusal of intralesional steroids and concerns about pain and the potential systemic toxicity of other options such as acitretin and methotrexate, and considering the shared involvement of the JAK/STAT pathway in both LSA and vitiligo, the patient was started on oral tofacitinib 5 mg once daily, following a short one-week course of oral steroids. Here, SOAT1 is linked to vitiligo.